483
OxiWear Inc.FDA 483 - OxiWear Inc. - July 30, 2025
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of OxiWear Inc. in Buffalo, NY, a medical device manufacturer, identified a significant deficiency in design input documentation. The firm failed to adequately document design input requirements for its OxiWear OxiV3 Ear-Wearable Continuous SpO2 Data Collection System, specifically concerning its intended use across all skin types. This indicates a moderate severity concern regarding the foundational design controls for their medical device.
- Office
- New York District Office
- Person
Open in Dashboard
ID · 6ec0cc9e-86f9-400e-8634-aca439410709